ACRS FY 2020 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$407M

FY 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$6M+53.3% YoY

Gross Profit

$1M20.8% margin

Operating Income

-$51M-785.4% margin

Net Income

-$51M-787.0% margin

EPS (Diluted)

$-1.20

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$39M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$71M

Total Liabilities

$33M

Stockholders' Equity

$38M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$4M	+53.3%
Gross Profit	$1M	$172,000	+684.3%
Operating Income	-$51M	-$111M	+54.2%
Net Income	-$51M	-$161M	+68.4%